Document:

EXHBIT 4.1

 Exhibit 4.1 
 CHASE ISSUANCE TRUST 
 as Issuing Entity 
 CLASS A(2007-17) TERMS DOCUMENT 
 dated as of October 15, 2007 
 to 
 AMENDED AND RESTATED 
 CHASESERIES INDENTURE SUPPLEMENT 
 dated as of October 15, 2004 
 to 
 SECOND AMENDED AND RESTATED 
 INDENTURE 
 dated as of March 14, 2006 
 WELLS FARGO BANK, NATIONAL ASSOCIATION 
 as Indenture Trustee and Collateral Agent 

 TABLE OF CONTENTS 
  

					
	 	  	PAGE
	ARTICLE I Definitions and Other Provisions of General Application
			
	Section 1.01	  	Definitions	  	1
	Section 1.02	  	Governing Law	  	3
	Section 1.03	  	Counterparts	  	4
	Section 1.04	  	Ratification of Indenture and Indenture Supplement	  	4
	
	ARTICLE II The Class A(2007-17) Notes
			
	Section 2.01	  	Creation and Designation	  	5
	Section 2.02	  	Specification of Required Subordinated Amount and Other Terms	  	5
	Section 2.03	  	Interest Payment	  	6
	Section 2.04	  	Payments of Interest and Principal	  	6
	Section 2.05	  	Form of Delivery of Class A(2007-17) Notes; Depository; Denominations.	  	6
	Section 2.06	  	Delivery and Payment for the Class A(2007-17) Notes	  	7
	Section 2.07	  	Supplemental Indenture	  	7

 THIS CLASS A(2007-17) TERMS DOCUMENT (this “Terms Document”), among the CHASE ISSUANCE TRUST, a
statutory trust created under the laws of the State of Delaware (the “Issuing Entity”), having its principal office at c/o Wilmington Trust Company, 1100 North Market Street, Wilmington, Delaware 19890-1600, and WELLS FARGO BANK, NATIONAL
ASSOCIATION, a national banking association, as indenture trustee (the “Indenture Trustee”) and as collateral agent (the “Collateral Agent”), is made and entered into as of October 15, 2007. 
 Pursuant to this Terms Document, the Issuing Entity and the Indenture Trustee shall create a new Tranche of CHASEseries Class A Notes and shall
specify the principal terms thereof. 
 ARTICLE I 
 Definitions and Other Provisions of General Application 
 Section 1.01 Definitions For all purposes
of this Terms Document, except as otherwise expressly provided or unless the context otherwise requires: 
 (1) the terms defined in this
Article have the meanings assigned to them in this Article, and include the plural as well as the singular; 
 (2) all other terms used
herein which are defined in the Indenture Supplement, the Indenture or the Asset Pool Supplement, either directly or by reference therein, have the meanings assigned to them therein; 
 (3) as used in this Terms Document and in any certificate or other document made or delivered pursuant hereto or thereto, accounting terms not defined in
this Terms Document or in any such certificate or other document, and accounting terms partly defined in this Terms Document or in any such certificate or other document to the extent not defined, shall have the respective meanings given to them
under GAAP. To the extent that the definitions of accounting terms in this Terms Document or in any such certificate or other document are inconsistent with the meanings of such terms under GAAP, the definitions contained in this Terms Document or
in any such certificate or other document shall control; 
 (4) the words “hereof,” “herein,” “hereunder” and
words of similar import when used in this Terms Document shall refer to this Terms Document as a whole and not to any particular provision of this Terms Document; references to any subsection, Section, clause, Schedule or Exhibit are references to
subsections, Sections, clauses, Schedules and Exhibits in or to this Terms Document unless otherwise specified; the term “including” means “including without limitation”; references to any law or regulation refer to that law or
regulation as amended from time to time and include any successor law or regulation; references to any Person include that Person’s successors and assigns; and references to any agreement refer to such agreement, as amended, supplemented or
otherwise modified from time to time; 

 (5) in the event that any term or provision contained herein shall conflict with or be inconsistent with
any term or provision contained in the Indenture Supplement, the Indenture or the Asset Pool Supplement, the terms and provisions of this Terms Document shall be controlling; and 
 (6) each capitalized term defined herein shall relate only to the Class A(2007-17) Notes and no other Tranche of CHASEseries Notes issued by the Issuing
Entity. 
 “Asset Pool Supplement” means the Amended and Restated Asset Pool One Supplement to the Indenture, dated as of
October 15, 2004, as amended by the First Amendment thereto, dated as of May 10, 2005, the Second Amendment thereto, dated as of February 1, 2006, and the Third Amendment thereto, dated as of September 27, 2007, by and among the
Issuing Entity, the Indenture Trustee and the Collateral Agent. 
 “Beneficiary” means Chase Bank USA, National Association,
in its capacity as beneficial owner of the Issuing Entity. 
 “Class A(2007-17) Adverse Event” means the occurrence of any
of the following: (a) an Early Amortization Event with respect to the Class A(2007-17) Notes, (b) an Event of Default and acceleration of the Class A(2007-17) Notes, (c) the Class A Usage of the Class B Required Subordinated
Amount for the Class A(2007-17) Notes becomes greater than zero or (d) the Class A Usage of the Class C Required Subordinated Amount for the Class A(2007-17) Notes becomes greater than zero. 
 “Class A(2007-17) Note” means any Note, substantially in the form set forth in Exhibit A-1 to the Indenture Supplement, designated
therein as a Class A(2007-17) Note and duly executed and authenticated in accordance with the Indenture. 
 “Class A(2007-17)
Noteholder” means a Person in whose name a Class A(2007-17) Note is registered in the Note Register. 
 “Class A(2007-17)
Termination Date” means the earliest to occur of (a) the Principal Payment Date on which the Outstanding Dollar Principal Amount of the Class A(2007-17) Notes is paid in full, (b) the Legal Maturity Date and (c) the date on
which the Indenture is discharged and satisfied pursuant to Article V thereof. 
 “Class A Required Subordinated Amount of Class B
Notes” is defined in Section 2.02(a). 
 “Class A Required Subordinated Amount of Class C Notes” is defined in
Section 2.02(b). 
 “Controlled Accumulation Amount” means $166,666,666.67; provided, however, if the
Accumulation Period Length is determined to be less than twelve months pursuant to Section 3.12(b)(ii) of the Indenture Supplement, the Controlled Accumulation Amount for any Note Transfer Date with respect to the Class A(2007-17) Notes will be

  

 2 

 
the amount specified in the definition of “Controlled Accumulation Amount” in the Indenture Supplement. 
 “Indenture” means the Second Amended and Restated Indenture, dated as of March 14, 2006, between the Issuing Entity and the
Indenture Trustee. 
 “Indenture Supplement” means the Amended and Restated CHASEseries Indenture Supplement, dated as of
October 15, 2004, among the Issuing Entity, the Indenture Trustee and the Collateral Agent. 
 “Initial Dollar Principal
Amount” means $2,000,000,000. 
 “Interest Payment Date” means November 15, 2007 and the 15th day of each
month thereafter, or if such 15th day is not a Business Day, the next succeeding Business Day. 
 “Interest Period” means,
with respect to any Interest Payment Date, the period from and including the previous Interest Payment Date (or in the case of the initial Interest Payment Date, from and including the Issuance Date) to but excluding such Interest Payment Date.

 “Issuance Date” means October 15, 2007. 
 “Legal Maturity Date” means October 15, 2014. 
 “Note Interest Rate” means a rate per annum equal to 5.12%. 
 “Paying
Agent” means Wells Fargo Bank, National Association. 
 “Predecessor Note” means, with respect to any particular
Note, every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purpose of this definition, any Note authenticated and delivered under Section 3.06 of the Indenture in lieu of a
mutilated, lost, destroyed or stolen Note shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note. 
 “Record Date” means, for any Note Transfer Date, the last Business Day of the preceding Monthly Period. 
 “Scheduled Principal Payment Date” means October 15, 2012. 
 “Stated Principal Amount” means
$2,000,000,000. 
 Section 1.02 Governing Law THIS TERMS DOCUMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF
THE STATE OF DELAWARE WITHOUT REFERENCE TO ITS CONFLICT OF LAW PROVISIONS AND THE OBLIGATIONS, RIGHTS AND REMEDIES 

  

 3 

 
OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. 
 Section 1.03 Counterparts This Terms Document may be executed in any number of counterparts, each of which so executed will be deemed to be an
original, but all such counterparts will together constitute but one and the same instrument. 
 Section 1.04 Ratification of Indenture
and Indenture Supplement As supplemented by this Terms Document, each of the Indenture, the Asset Pool Supplement and the Indenture Supplement is in all respects ratified and confirmed and the Indenture as so supplemented by the Asset Pool
Supplement and the Indenture Supplement as so supplemented by this Terms Document shall be read, taken and construed as one and the same instrument. 
 [END OF ARTICLE I] 
  

 4 

 ARTICLE II 
 The Class A(2007-17) Notes 
 Section 2.01 Creation and Designation There is hereby created a Tranche
of CHASEseries Class A Notes to be issued pursuant to the Indenture and the Indenture Supplement to be known as the “CHASEseries Class A(2007-17) Notes.” 
 Section 2.02 Specification of Required Subordinated Amount and Other Terms 
 (a) For the Class
A(2007-17) Notes for any date of determination, the Class A Required Subordinated Amount of Class B Notes will be an amount equal to 6.49718% of (i) prior to the occurrence of a Class A(2007-17) Adverse Event, the Adjusted Outstanding
Dollar Principal Amount of the Class A(2007-17) Notes on such date of determination or (ii) on and after the date on which a Class A(2007-17) Adverse Event shall have occurred, the greater of (1) the Adjusted Outstanding Dollar Principal
Amount of the Class A(2007-17) Notes on such date of determination and (2) the Adjusted Outstanding Dollar Principal Amount of the Class A(2007-17) Notes as of the close of business on the day immediately preceding the date on which such Class
A(2007-17) Adverse Event shall have occurred. 
 (b) For the Class A(2007-17) Notes for any date of determination, the Class A Required
Subordinated Amount of Class C Notes will be an amount equal to 6.49718% of (i) prior to the occurrence of a Class A(2007-17) Adverse Event, the Adjusted Outstanding Dollar Principal Amount of the Class A(2007-17) Notes on such date or
(ii) on and after the date on which a Class A(2007-17) Adverse Event shall have occurred, the greater of (1) the Adjusted Outstanding Dollar Principal Amount of the Class A(2007-17) Notes on such date of determination and (2) Adjusted
Outstanding Dollar Principal Amount of the Class A(2007-17) Notes as of the close of business on the day immediately preceding the date on which such Class A(2007-17) Adverse Event shall have occurred. 
 (c) The Issuing Entity may change the percentages or the formulas set forth in either clause (a) or (b) above without the consent of any
Noteholder so long as the Issuing Entity has (i) received written confirmation from each Note Rating Agency that has rated any Outstanding Notes that the change in either of such percentages or formulas, as applicable, will not result in a
Ratings Effect with respect to any Outstanding Notes and (ii) delivered to the Indenture Trustee and the Note Rating Agencies a Master Trust Tax Opinion and an Issuing Entity Tax Opinion. 
  

 5 

 Section 2.03 Interest Payment 
 (a) For each Interest Payment Date, the amount of interest due with respect to the Class A(2007-17) Notes shall be an amount equal to one-twelfth the
product of (i) the Note Interest Rate times, (ii) the Outstanding Dollar Principal Amount of the Class A(2007-17) Notes determined as of the close of business on the Interest Payment Date preceding the related Note Transfer Date for
the Class A(2007-17) Notes; provided, however, that for the first Interest Payment Date, the amount of interest due with respect to the Class A(2007-17) Notes is $8,533,333.33. Interest on the Class A(2007-17) Notes will be calculated
on the basis of a 360-day year consisting of twelve 30-day months. 
 (b) Pursuant to Section 3.03 of the Indenture Supplement, on each
Note Transfer Date with respect to the Class A(2007-17) Notes, the Indenture Trustee shall deposit into the Class A(2007-17) Interest Funding Sub-Account the portion of CHASEseries Available Finance Charge Collections allocable to the Class
A(2007-17) Notes. 
 Section 2.04 Payments of Interest and Principal 
 (a) Any installment of interest or principal payable on any Class A(2007-17) Note which is punctually paid or duly provided for by the Issuing Entity and
the Indenture Trustee on the applicable Interest Payment Date or Principal Payment Date shall be paid by the Paying Agent to the Person in whose name such Class A(2007-17) Note (or one or more Predecessor Notes) is registered on the Record Date, by
wire transfer of immediately available funds to such Person’s account as has been designated by written instructions received by the Paying Agent from such Person not later than the close of business on the third Business Day preceding the date
of payment or, if no such account has been so designated, by check mailed first-class, postage prepaid to such Person’s address as it appears on the Note Register on such Record Date, except that with respect to Notes registered on the Record
Date in the name of the nominee of Cede & Co., payment shall be made by wire transfer in immediately available funds to the account designated by such nominee. 
 (b) The right of the Class A(2007-17) Noteholders to receive payments from the Issuing Entity will terminate on the first Business Day following the Class A(2007-17) Termination Date. 
 Section 2.05 Form of Delivery of Class A(2007-17) Notes; Depository; Denominations. 
 (a) The Class A(2007-17) Notes shall be delivered in the form of a global Registered Note as provided in Sections 2.02 and 3.01(i) of the Indenture,
respectively. 
  

 6 

 (b) The Depository for the Class A(2007-17) Notes shall be The Depository Trust Company, and the Class
A(2007-17) Notes shall initially be registered in the name of Cede & Co., its nominee. 
 (c) The Class A(2007-17) Notes will be
issued in minimum denominations of $100,000 and integral multiples of $1,000 in excess of $100,000. 
 Section 2.06 Delivery and Payment
for the Class A(2007-17) Notes The Issuing Entity shall execute and deliver the Class A(2007-17) Notes to the Indenture Trustee for authentication, and the Indenture Trustee shall deliver the Class A(2007-17) Notes when authenticated, each in
accordance with Section 3.03 of the Indenture. 
 Section 2.07 Supplemental Indenture The Issuing Entity may enter into a
supplemental indenture with respect to the Class A(2007-17) Notes as provided in Section 9.01 of the Indenture; provided, however, that any supplemental indenture which provides for an additional or alternative form of credit
enhancement for the Class A(2007-17) Notes shall, in addition to the requirements set forth in Section 9.01 of the Indenture, require confirmation from the Note Rating Agencies that have rated any Outstanding Notes of the CHASEseries that such
change in credit enhancement will not result in a Ratings Effect with respect to any Outstanding Notes of the CHASEseries. 
 [END OF ARTICLE
II] 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Terms Document to be duly executed, all as of the
day and year first above written. 
  

			
	CHASE ISSUANCE TRUST
		
	By:	 	 CHASE BANK USA, NATIONAL ASSOCIATION,
 as Beneficiary and not in its individual capacity

		
	By:	 	 /s/ Keith W. Schuck

	Name:	 	Keith W. Schuck
	Title:	 	President
	
	 WELLS FARGO BANK, NATIONAL ASSOCIATION,
 as Indenture Trustee and Collateral Agent

		
	By:	 	 /s/ Cheryl C. Zimmerman

	Name:	 	Cheryl C. Zimmerman, CCTS
	Title:	 	Assistant Vice PresidentForm of Stock Appreciation Rights Agreement

 Exhibit 10.1 
 STOCK APPRECIATION RIGHTS AGREEMENT 
 PURSUANT TO THE 
 CROSS COUNTRY HEALTHCARE, INC. 
 2007 STOCK INCENTIVE PLAN 
 THIS AGREEMENT (this “Agreement”), made as of the
     day of             , 20     (the “Grant Date”), by and between Cross Country Healthcare, Inc.(the
“Company”) and                      (the “Participant”). 
 Preliminary Statement 
 The Board of
Directors of the Company (the “Board”) or a committee appointed by the Board (the “Committee”) to administer the Cross Country Healthcare, Inc. 2007 Stock Incentive Plan (the “Plan”), has authorized
this grant of Non-Tandem Stock Appreciation Rights (“SARs”) to the Participant, as an Eligible Employee of the Company or an Affiliate (collectively, the Company and all Affiliates and Parents of the Company shall be referred to as
the “Employer”). Unless otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan. A copy of the Plan has been delivered to the Participant. By signing and
returning this Agreement, the Participant acknowledges having received and read a copy of the Plan and agrees to comply with it, this Agreement and all applicable laws and regulations. 
 Accordingly, the parties hereto agree as follows: 
 1. Grant of SARs. Subject in all respects to the Plan and the terms and conditions set forth
herein and therein, the Participant is hereby granted                      SARs entitling the Participant to receive, for each of the SARs
exercised, up to, but no more than, an amount in Common Stock equal in value to the excess of the Fair Market Value of one share of Common Stock on the date the SARs are exercised over
$            .1 Fractional shares of Common Stock resulting from any exercise of the SARs shall be aggregated until, and eliminated at, the time of exercise by rounding-down for fractions less than one-half and rounding-up for
fractions equal to or greater than one-half. No cash settlements shall be made with respect to fractional shares eliminated by rounding. 
 2. Exercise. (a) The SARs will become exercisable in installments as provided below, which shall be cumulative. To the extent that the SARs have become exercisable with respect to a percentage of the SARs
granted, the SARs may thereafter be exercised by the Participant, in whole or in part, at any time or from time to time prior to the expiration of the SARs. The 
  

 1 Insert Fair Market Value of one share of Common Stock on the grant date. 

 
following table indicates the dates (each a “Vesting Date” and collectively, the “Vesting Dates”) upon which the
Participant shall be entitled to exercise the SARs, provided that the Participant has been continuously employed by the Company or an Affiliate through each applicable Vesting Date: 
  

			
	 Vesting Date
	  	 Percentage of SARs

	 First Anniversary of Grant Date
	  	25%
	 Second Anniversary of Grant Date
	  	25%
	 Third Anniversary of Grant Date
	  	25%
	 Fourth Anniversary of Grant Date
	  	25%

 To the extent that the SARs become vested and exercisable with respect to a percentage of SARs as
provided above, the SARs may thereafter be exercised by the Participant, in whole or in part, at any time or from time to time prior to the expiration or termination of the SARs as provided in Sections 3 and 4 of this Agreement by giving written
notice of exercise to the Company specifying the number of SARs to be exercised. Upon expiration of the SARs, the SARs shall be canceled and no longer exercisable. 
 There shall be no proportionate or partial vesting in the periods prior to each vesting date and all vesting shall occur only on the appropriate vesting date. 
 (b) The provisions in Section 7.4(c) of the Plan regarding Detrimental Activity shall [not] apply to the SARs. 
 (c) The SARs will [not] become fully vested on a Change in Control 
 3. Term. The term of the SARs shall be seven (7) years after the Grant Date, subject to earlier termination in the event of the Participant’s Termination as specified in Section 4 below.

 4. Termination. 
 Subject to the terms of the Plan and this Agreement, the SARs, to the extent vested at the time of
the Participant’s Termination, shall remain exercisable as follows:2 
 (a) In the event of the Participant’s Termination by reason of death, Disability, or Retirement, the vested portion of the SARs shall remain
exercisable until the earlier of (i) one (1) year from the date of such Termination or (ii) the expiration of the stated term of the SARs pursuant to Section 3 hereof; provided, however, that in the case of Disability or
Retirement, if the Participant dies within such one (1) year exercise period, any unexercised SARs held by the Participant shall thereafter be exercisable by the legal representative of the Participant’s estate, to the extent to which it
was exercisable at the time of death, for a period of one (1) year from the date of death, but in no event beyond the expiration of the stated term of the SARs pursuant to Section 3 hereof. 

	 2
	 These termination provisions are consistent with the termination provisions set
forth in the Plan. The Committee has the discretion to modify these provisions and provide alternative post-termination exercise periods. 

  

 2 

 (b) In the event of the Participant’s involuntary Termination without Cause, any SARs that are
vested and exercisable at the time of the Participant’s Termination shall remain exercisable until the earlier of (i) ninety (90) days from the date of such Termination or (ii) the expiration of the stated term of the SARs
pursuant to Section 3 hereof. 
 (c) In the event of the Participant’s voluntary Termination (other than a voluntary termination
described in Section 4(d) below, or a Retirement), the vested portion of the SARs shall remain exercisable until the earlier of (i) thirty (30) days from the date of such Termination or (ii) the expiration of the stated term of
the SARs pursuant to Section 3 hereof. 
 (d) In the event of the Participant’s Termination for Cause or in the event of the
Participant’s voluntary Termination or Retirement, in each case after the occurrence of an event that would be grounds for a Termination for Cause, all of the Participant’s SARs (whether or not vested) shall terminate and expire upon such
Termination. 
 (e) Any portion of the SARs that is not vested as of the date of the Participant’s Termination for any reason shall
terminate and expire as of the date of such Termination. 
 5. Restriction on Transfer of SARs. No part of the SARs shall be
Transferred other than by will or by the laws of descent and distribution and during the lifetime of the Participant, may be exercised only by the Participant. In addition, the SARs shall not be assigned, negotiated, pledged or hypothecated in any
way (except as provided by law or herein), and the SARs shall not be subject to execution, attachment or similar process. Upon any attempt to Transfer the SARs or in the event of any levy upon the SARs by reason of any execution, attachment or
similar process contrary to the provisions hereof, such transfer shall be void and of no effect and the Company shall have the right to disregard the same on its books and records and to issue “stop transfer” instructions to its transfer
agent. 
 6. Rights as a Stockholder. The Participant shall have no rights as a stockholder with respect to any shares payable upon
exercise of the SARs unless and until the Participant has become the holder of record of the shares, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any such shares, except as
otherwise specifically provided for in the Plan. 
 7. Provisions of Plan Control. This Agreement is subject to all the terms,
conditions and provisions of the Plan, including, without limitation, the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be adopted by the Committee and as may be in effect from time to
time. The Plan is incorporated herein by reference. If and to the extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of the Plan, the Plan shall control, and this Agreement shall be deemed to be
modified accordingly. This Agreement contains the entire understanding of the parties with 

  

 3 

 
respect to the subject matter hereof (other than any exercise notice or other documents expressly contemplated herein or in the Plan) and supersedes any
prior agreements between the Company and the Participant with respect to the subject matter hereof. 
 8. Amendment. To the extent
applicable, the Board or the Committee may at any time and from time to time amend, in whole or in part, any or all of the provisions of this Agreement to comply with Section 409A of the Code and the regulations thereunder or any other
applicable law and may also amend, suspend or terminate this Agreement subject to the terms of the Plan. 
 9. Notices. Any notice or
communication given hereunder (each a “Notice”) shall be in writing and shall be sent by personal delivery, by courier or by United States mail (registered or certified mail, postage prepaid and return receipt requested), to
the appropriate party at the address set forth below: 
 If to the Company, to: 
 Cross Country Healthcare, Inc. 
 6551 Park of
Commerce Blvd. 
 Boca Raton, Florida 33487 
 Attention: Paula C. Donayri, Corporate Benefits Manager 
 If to the Participant, to the address for the
Participant on file with the Company; 
 or such other address or to the attention of such other person as a party shall have specified by
prior Notice to the other party. Each Notice will be deemed given and effective upon actual receipt (or refusal of receipt). 
 10. No
Obligation to Continue Employment. This Agreement is not an agreement of employment. This Agreement does not guarantee that the Employer will employ the Participant for any specific time period, nor does it modify in any respect the
Employer’s right to terminate or modify the Participant’s employment or compensation. 
 11. Governing Law. All questions
concerning the construction, validity and interpretation of this Agreement will be governed by, and construed in accordance with, the domestic laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or
rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. 
 12. Consent to Jurisdiction. In the event of any dispute, controversy or claim between the Company or any Affiliate and the Participant in any way concerning, arising out of or relating to the Plan or this
Agreement (a “Dispute”), including without limitation any Dispute concerning, arising out of or relating to the interpretation, application or enforcement of the Plan or this Agreement, the parties hereby (a) agree and
consent to the personal jurisdiction of the courts of the State of Florida located in Palm Beach County and/or the Federal courts of the United States of 

  

 4 

 
America located in the Florida Southern District (collectively, the “Agreed Venue”) for resolution of any such Dispute,
(b) agree that those courts in the Agreed Venue, and only those courts, shall have exclusive jurisdiction to determine any Dispute, including any appeal, and (c) agree that any cause of action arising out of this Agreement shall be deemed
to have arisen from a transaction of business in the State of Florida. The parties also hereby irrevocably (i) submit to the jurisdiction of any competent court in the Agreed Venue (and of the appropriate appellate courts therefrom),
(ii) to the fullest extent permitted by law, waive any and all defenses the parties may have on the grounds of lack of jurisdiction of any such court and any other objection that such parties may now or hereafter have to the laying of the venue
of any such suit, action or proceeding in any such court (including without limitation any defense that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum), and (iii) consent to service of
process in any such suit, action or proceeding, anywhere in the world, whether within or without the jurisdiction of any such court, in any manner provided by applicable law. Without limiting the foregoing, each party agrees that service of process
on such party pursuant to a Notice as provided in Section 9 shall be deemed effective service of process on such party. Any action for enforcement or recognition of any judgment obtained in connection with a Dispute may enforced in any
competent court in the Agreed Venue or in any other court of competent jurisdiction. 
 13. Counterparts. This Agreement may be
executed (including by facsimile transmission) with counterpart signature pages or in separate counterparts each of which shall be an original and all of which taken together shall constitute one and the same agreement. 
 14. Miscellaneous. 
 (a) This
Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, legal representatives, successors and assigns. 
 (b) The failure of any party hereto at any time to require performance by another party of any provision of this Agreement shall not affect the right of such party to require performance of that provision, and any
waiver by any party of any breach of any provision of this Agreement shall not be construed as a waiver of any continuing or succeeding breach of such provision, a waiver of the provision itself, or a waiver of any right under this Agreement.

 [Remainder of page intentionally left blank – signature page follows] 
  

 5 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above
written. 
  

							
	PARTICIPANT:	 		 	CROSS COUNTRY HEALTHCARE, INC.
				
	  
	 		 	By:	 	  

	First and Last Name	 		 		 	Emil Hensel, Chief Financial Officer

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}]]